As a researcher, Dr. Joseph has served as an investigator on over 100 clinical trials with adults and children. His research has contributed to finding new treatments for a variety of psychiatric conditions.
Dr. Joseph has conducted clinical trials involving new pharmacologic agents in a variety of disorders including: Depression, Bipolar Disorder, Generalized Anxiety Disorder, Attention Deficit Disorder, Schizophrenia, Sleep Disorders, Migraine Headache Disorder, Insomnia, Social Phobia and Fibromyalgia.
|Generalized Anxiety Disorder
Social Anxiety Disorder
A clinical trial is a research study in human volunteers to answer specific health questions.
For most trials, researchers, doctors, and other health professionals administer the clinical trials according to strict rules set by the Food and Drug Administration (FDA). FDA sets the rules to make sure that people who agree to be in studies are treated as safely as possible.
Careful and professionally conducted clinical trial is the safest and fastest way to find treatments that work in people, and new ways to improve health.
Clinical trials are sometimes used to compare current treatments, or to study different ways to utilize current treatments to increase their efficacy and/or to decrease side effects.
Sometimes, studies are created to explore the use of certain treatments in a specific population, as in children, whom have not yet been tested.
The ethical and legal codes that govern medical practice also apply to clinical trials. The federal government has regulations and guidelines for clinical research to protect participants from unreasonable risks.
Though efforts are made to control the risks to clinical trial participants, some risks may be unavoidable due to the uncertainty in medical research studies involving new medical treatments.
Participants must sign an “informed consent” document before joining the study indicating they understand that the trial is research, and that they can leave the clinical trial at any time.
This informed consent is part of a process that ensures a prospective participant in a clinical trial understands what known risks might be associated with the study, and whether there are potential, but as yet unknown risks that may be associated with the product being studied. This information permits someone deciding whether or not to enter a clinical trial to make an informed decision about the level of risk they are willing to accept before they enter the trial.
We are testing the effects of a potential new medication or one that is already on the market (like Pristiq, Celexa, Cymbalta, Effexor, etc.) in another age, dose or disorder by asking volunteers to be in a study.
Compensation is provided for most of our studies. Each study varies in the amount provided, but the average is about $40 at each visit during the study.